Flutter Over Debut Of Glenmark's Favipiravir For COVID-19 In India

Poised For Scale-Up Using In-House Capabilities

Coronavirus COVID-19 medical test vaccine research and development concept. Scientist in laboratory study and analyze scientific sample of Coronavirus antibody to produce drug treatment for COVID-19.
Favipiravir Gets India Green Light After Accelerated Approval • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia